UFF
CRL icon

USA Financial Formulas’s Charles River Laboratories CRL Stock Holding History

USA Financial Formulas’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 375
2021
Q4 		$0 Sell
1
-2,672
-100% -$1.04M ﹤0.01% 395
2021
Q3 		$1.1M Buy
2,673
+1,526
+133% +$634K 0.99% 35
2021
Q2 		$424K Buy
1,147
+214
+23% +$71.5K 0.36% 87
2021
Q1 		$270K Buy
+933
New +$259K 0.22% 115
2020
Q4 		– Sell
-1,633
Closed -$370K – 335
2020
Q3 		$370K Buy
+1,633
New +$339K 0.28% 90
2017
Q4 		– Sell
-5,390
Closed -$582K – 276
2017
Q3 		$582K Buy
+5,390
New +$554K 0.14% 142
2015
Q2 		– Sell
-6,807
Closed -$540K – 225
2015
Q1 		$540K Buy
+6,807
New +$502K 0.18% 93

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return